Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Kefford

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Internal Medicine Journal|May 27, 2015
Ipilimumab-induced hypophysitis in melanoma patients: an Australian case seriesT Lam, M M K Chan, A N Sweeting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanomaJ H Lee, G V Long, S Boyd, et al.
Oncoimmunology|October 21, 2016
Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanomaE Liniker, A M Menzies, B Y Kong, et al.
British Journal of Cancer|June 12, 2014
Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanomaM S Carlino, L E Haydu, H Kakavand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2019
Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patientsJ H Lee, R P Saw, J F Thompson, et al.
Annals of Internal Medicine|October 1, 1994
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trialD W Maher, G J Lieschke, M Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trialA M Menzies, M T Ashworth, S Swann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 16, 2019
Associations of pigmentary and naevus phenotype with melanoma risk in two populations with comparable ancestry but contrasting levels of ambient sun exposureA E Cust, M Drummond, D T Bishop, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Internal Medicine Journal|May 27, 2015
Ipilimumab-induced hypophysitis in melanoma patients: an Australian case seriesT Lam, M M K Chan, A N Sweeting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanomaJ H Lee, G V Long, S Boyd, et al.
Oncoimmunology|October 21, 2016
Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanomaE Liniker, A M Menzies, B Y Kong, et al.
British Journal of Cancer|June 12, 2014
Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanomaM S Carlino, L E Haydu, H Kakavand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2019
Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patientsJ H Lee, R P Saw, J F Thompson, et al.
Annals of Internal Medicine|October 1, 1994
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trialD W Maher, G J Lieschke, M Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trialA M Menzies, M T Ashworth, S Swann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 16, 2019
Associations of pigmentary and naevus phenotype with melanoma risk in two populations with comparable ancestry but contrasting levels of ambient sun exposureA E Cust, M Drummond, D T Bishop, et al.
Pageof 9